Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Osteoporosis

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 542 articles:
HTML format
Text format



Single Articles


    March 2017
  1. CHEN YY, Feng JY, Ting WY, Yen YF, et al
    Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
    Osteoporos Int. 2017 Mar 22. doi: 10.1007/s00198-017-3939.
    PubMed     Text format     Abstract available


  2. MORIWAKI K, Mouri M, Hagino H
    Erratum to: Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-4006.
    PubMed     Text format    


  3. LAINE CM, Landin-Wilhelmsen K
    Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-3981.
    PubMed     Text format     Abstract available


  4. THOMPSON MJ, Aitken DA, Otahal P, Cicolini J, et al
    The relationship between cumulative lifetime ultraviolet radiation exposure, bone mineral density, falls risk and fractures in older adults.
    Osteoporos Int. 2017 Mar 20. doi: 10.1007/s00198-017-4001.
    PubMed     Text format     Abstract available


  5. LOOKER AC, Sarafrazi Isfahani N, Fan B, Shepherd JA, et al
    Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014.
    Osteoporos Int. 2017 Mar 18. doi: 10.1007/s00198-017-3996.
    PubMed     Text format     Abstract available


  6. MOHD-TAHIR NA, Li SC
    Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3985.
    PubMed     Text format     Abstract available


  7. ASADIPOOYA K, Graves L, Greene LW
    Transient osteoporosis of the hip: review of the literature.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3952.
    PubMed     Text format     Abstract available


  8. POPP AW, Senn R, Curkovic I, Senn C, et al
    Factors associated with acute-phase response of bisphosphonate-naive or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
    Osteoporos Int. 2017 Mar 15. doi: 10.1007/s00198-017-3992.
    PubMed     Text format     Abstract available


  9. CHANG HK, Chang DG, Myong JP, Kim JH, et al
    Bone mineral density among Korean females aged 20-50 years: influence of age at menarche (The Korea National Health and Nutrition Examination Survey 2008-2011).
    Osteoporos Int. 2017 Mar 14. doi: 10.1007/s00198-017-3997.
    PubMed     Text format     Abstract available


  10. EASTELL R, Diez-Perez A
    Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3991.
    PubMed     Text format    


  11. ZHOU YH, Sheng ZF
    Comments on Diez-Perez et al.: Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3987.
    PubMed     Text format    


  12. MAJUMDAR SR, Lier DA, Hanley DA, Juby AG, et al
    Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Osteoporos Int. 2017 Mar 9. doi: 10.1007/s00198-017-3986.
    PubMed     Text format     Abstract available


  13. IMAI T, Tanaka S, Kawakami K, Miyazaki T, et al
    Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3966.
    PubMed     Text format     Abstract available


  14. MORIWAKI K, Mouri M, Hagino H
    Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3973.
    PubMed     Text format     Abstract available


  15. KERR C, Bottomley C, Shingler S, Giangregorio L, et al
    The importance of physical function to people with osteoporosis.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3911.
    PubMed     Text format     Abstract available


  16. HAN MH, Ryu JI, Kim CH, Kim JM, et al
    Influence of systemic bone mineral density on atlantoaxial subluxation in patients with rheumatoid arthritis.
    Osteoporos Int. 2017 Mar 2. doi: 10.1007/s00198-017-3972.
    PubMed     Text format     Abstract available


  17. WEI Y, Tian W, Zhang GL, Lv YW, et al
    Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women.
    Osteoporos Int. 2017 Mar 1. doi: 10.1007/s00198-017-3971.
    PubMed     Text format     Abstract available


    February 2017
  18. TAMAKI J, Iki M, Sato Y, Kajita E, et al
    Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3967.
    PubMed     Text format     Abstract available


  19. DU Y, Zhao LJ, Xu Q, Wu KH, et al
    Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3951.
    PubMed     Text format     Abstract available


  20. MORFELD JC, Vennedey V, Muller D, Pieper D, et al
    Patient education in osteoporosis prevention: a systematic review focusing on methodological quality of randomised controlled trials.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3946.
    PubMed     Text format     Abstract available


  21. ROUX C, Briot K
    Imminent fracture risk.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3976.
    PubMed     Text format     Abstract available


  22. LEE SH, Hsu WT, Lai CC, Esmaily-Fard A, et al
    Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Feb 23. doi: 10.1007/s00198-017-3938.
    PubMed     Text format    


  23. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Osteoporos Int. 2017 Feb 17. doi: 10.1007/s00198-017-3940.
    PubMed     Text format     Abstract available


  24. COLARES NETO GP, Pereira RM, Alvarenga JC, Takayama L, et al
    Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3949.
    PubMed     Text format     Abstract available


  25. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3927.
    PubMed     Text format    


  26. MORTON A
    A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3922.
    PubMed     Text format    


  27. LEE DY, Jee JH, Cho YY, Jang JY, et al
    Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
    Osteoporos Int. 2017 Feb 10. doi: 10.1007/s00198-016-3892.
    PubMed     Text format     Abstract available


  28. BALLANE G, Cauley JA, Luckey MM, El-Hajj Fuleihan G, et al
    Worldwide prevalence and incidence of osteoporotic vertebral fractures.
    Osteoporos Int. 2017 Feb 6. doi: 10.1007/s00198-017-3909.
    PubMed     Text format     Abstract available


  29. LESPESSAILLES E, Cortet B, Legrand E, Guggenbuhl P, et al
    Low-trauma fractures without osteoporosis.
    Osteoporos Int. 2017 Feb 4. doi: 10.1007/s00198-017-3921.
    PubMed     Text format     Abstract available


  30. MIKULA AL, Hetzel SJ, Binkley N, Anderson PA, et al
    Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3937.
    PubMed     Text format     Abstract available


    January 2017
  31. FU SJ, Sheng ZF
    Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-016-3867.
    PubMed     Text format    


  32. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-017-3923.
    PubMed     Text format    


  33. OKUBO R, Sanada LS, Castania VA, Louzada MJ, et al
    Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Osteoporos Int. 2017 Jan 26. doi: 10.1007/s00198-017-3905.
    PubMed     Text format     Abstract available


  34. ALACREU E, Moratal D, Arana E
    Opportunistic screening for osteoporosis by routine CT in Southern Europe.
    Osteoporos Int. 2017 Jan 20. doi: 10.1007/s00198-016-3804.
    PubMed     Text format     Abstract available


  35. DIEZ-PEREZ A, Naylor KE, Abrahamsen B, Agnusdei D, et al
    International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Jan 16. doi: 10.1007/s00198-017-3906.
    PubMed     Text format     Abstract available


  36. HONG AR, Kim JH, Lee KH, Kim TY, et al
    Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3899.
    PubMed     Text format     Abstract available


  37. LIM Y, Jo K, Ha HS, Yim HW, et al
    The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3893.
    PubMed     Text format     Abstract available


  38. LEE SH, Hsu WT, Lai CC, Amin EF, et al
    Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3881.
    PubMed     Text format     Abstract available


  39. HADJI P, Boekhoff J, Hahn M, Hellmeyer L, et al
    Pregnancy-associated osteoporosis: a case-control study.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3897.
    PubMed     Text format     Abstract available


  40. MODI A, Sajjan S, Insinga R, Weaver J, et al
    Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.
    Osteoporos Int. 2017 Jan 5. doi: 10.1007/s00198-016-3886.
    PubMed     Text format     Abstract available


    December 2016
  41. JOHANSSON H, Siggeirsdottir K, Harvey NC, Oden A, et al
    Imminent risk of fracture after fracture.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3868.
    PubMed     Text format     Abstract available


  42. MANA DL, Zanchetta MB, Zanchetta JR
    Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  43. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  44. FECHTENBAUM J, Kolta S, Briot K, Roux C, et al
    Vertebral fracture assessment by dual X-ray absorptiometry.
    Osteoporos Int. 2016.
    PubMed     Text format    


  45. RUD B, Hyldstrup L
    Vertebral fracture assessment by dual X-ray absorptiometry: reply to comments by Fechtenbaum et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  46. OTA M, Takahata M, Shimizu T, Kanehira Y, et al
    Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  47. CHEN GD, Ding D, Tian HY, Zhu YY, et al
    Adherence to the 2006 American Heart Association's Diet and Lifestyle Recommendations for cardiovascular disease risk reduction is associated with bone mineral density in older Chinese.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  48. CORREA CB, Camargos GV, Chatterjee M, Mesquita MF, et al
    Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  49. CIRNIGLIARO CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, et al
    Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  50. JAMAL SA, Reid LS, Hamilton CJ
    Statement of concern re: The effects of organic nitrates on osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format    


  51. JAMAL SA, Goltzman D, Hanley DA, Papaioannou A, et al
    Retraction to: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  52. ZHANG J, Hu X, Zhang J
    Associations between serum vitamin E concentration and bone mineral density in the US elderly population.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    November 2016
  53. MAWATARI T, Muraoka R, Iwamoto Y
    Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  54. NOGUCHI T, Ebina K, Hirao M, Morimoto T, et al
    Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  55. AN T, Hao J, Sun S, Li R, et al
    Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  56. JACOB L, Kostev K
    Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  57. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  58. SANCHEZ A, Blanco R
    Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  59. KIM H, Baek KH, Lee SY, Ahn SH, et al
    Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  60. KRUSE C, Eiken P, Vestergaard P
    Clinical fracture risk evaluated by hierarchical agglomerative clustering.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  61. ZHU W, Shen H, Zhang JG, Zhang L, et al
    Cytosolic proteome profiling of monocytes for male osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  62. RAY R, Clement ND, Aitken SA, McQueen MM, et al
    High mortality in younger patients with major osteoporotic fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  63. GARCIA-HOYOS M, Garcia-Unzueta MT, de Luis D, Valero C, et al
    Diverging results of areal and volumetric bone mineral density in Down syndrome.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  64. MATHAVAN N, Tagil M, Isaksson H
    Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available



  65. ABSTRACTS OF OSTEOPOROSIS CONFERENCE 2016.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  66. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Author index.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  67. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Plenary Lectures.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  68. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Oral Communications.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  69. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Poster Presentations.
    Osteoporos Int. 2016;27.
    PubMed     Text format    


    October 2016
  70. ZERBINI CA, Clark P, Mendez-Sanchez L, Pereira RM, et al
    Biologic therapies and bone loss in rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  71. BEATON DE, Vidmar M, Pitzul KB, Sujic R, et al
    Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  72. BELHASSEN M, Confavreux CB, Cortet B, Lamezec L, et al
    Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  73. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Erratum to: Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  74. HARVEY NC, Biver E, Kaufman JM, Bauer J, et al
    The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Fo
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  75. TSENTIDIS C, Gourgiotis D, Kossiva L, Marmarinos A, et al
    Increased levels of Dickkopf-1 are indicative of Wnt/beta-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  76. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  77. CHOI HS, Park JH, Kim SH, Shin S, et al
    Strong familial association of bone mineral density between parents and offspring: KNHANES 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  78. YOSHIMURA M, Moriwaki K, Noto S, Takiguchi T, et al
    A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  79. FARMER S, Shanbhogue VV, Hansen S, Stahlberg CI, et al
    Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  80. SU Y, Leung J, Hans D, Aubry-Rozier B, et al
    Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  81. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  82. PIRRO M, Mannarino MR, Bianconi V, De Vuono S, et al
    Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  83. WALLACE ER, Siscovick DS, Sitlani CM, Dublin S, et al
    Incident atrial fibrillation and the risk of fracture in the cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  84. RODRIGUES IB, Armstrong JJ, Adachi JD, MacDermid JC, et al
    Facilitators and barriers to exercise adherence in patients with osteopenia and osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  85. KAMYCHEVA E, Goto T, Camargo CA Jr
    Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  86. MORIWAKI K, Noto S
    Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  87. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  88. XU MH, Li X, Yuan FL
    Is it necessary to investigate rapamycin-modulated autophagy during the development of experimental osteoporosis in female rat?
    Osteoporos Int. 2016.
    PubMed     Text format    


  89. CHAKHTOURA M, Leslie WD, McClung M, Cheung AM, et al
    The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  90. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  91. AVENELL A, Bolland MJ, Grey A, Reid IR, et al
    Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention.
    Osteoporos Int. 2016.
    PubMed     Text format    


  92. SMALLWOOD AJ, Schapira MM, Fedders M, Neuner JM, et al
    A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  93. WU X, Wei D, Sun B, Wu XN, et al
    Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  94. BALOGH R, Wood J, Dobranowski K, Lin E, et al
    Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  95. NAKAMURA T, Fukunaga M, Nakano T, Kishimoto H, et al
    Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  96. CATALANO A, Vita GL, Russo M, Vita G, et al
    Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  97. AUBRY-ROZIER B, Fabreguet I, Iglesias K, Lamy O, et al
    Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    August 2016
  98. NI W, Jiang Y
    Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  99. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Time course of osteoporotic vertebral fractures by magnetic resonance imaging using a simple classification: a multicenter prospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  100. DUAN X, Wang J, Jiang X
    A meta-analysis of breastfeeding and osteoporotic fracture risk in the females.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  101. SU Y, Leung J, Hans D, Lamy O, et al
    The added value of trabecular bone score to FRAX(R) to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  102. BUCHELE G, Becker C, Cameron ID, Auer R, et al
    Fracture risk in people with developmental disabilities: results of a large claims data analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  103. POP LC, Sukumar D, Schneider SH, Schlussel Y, et al
    Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  104. LU PC, Yang YH, Guo SE, Yang TM, et al
    Factors associated with osteoporosis in patients with chronic obstructive pulmonary disease-a nationwide retrospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  105. HWANG J, Lee EK, Ahn JK, Cha HS, et al
    Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  106. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  107. CLARK E
    Health-related quality of life in older people with osteoporotic vertebral fractures: response to comments by Sani et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  108. SANI M, Ayubi E, Khazaei S, Mansori K, et al
    Health-related quality of life in older people with osteoporotic vertebral fractures: clinically important vs. statistically significant.
    Osteoporos Int. 2016.
    PubMed     Text format    


  109. KIM MK, Chon SJ, Noe EB, Roh YH, et al
    Associations of dietary calcium intake with metabolic syndrome and bone mineral density among the Korean population: KNHANES 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  110. SCHOUSBOE JT, Riekkinen O, Karjalainen J
    Prediction of hip osteoporosis by DXA using a novel pulse-echo ultrasound device.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  111. KIM YW, Kim JH, Yoon SH, Lee JH, et al
    Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  112. HANSEN L, Petersen KD, Eriksen SA, Gerstoft F, et al
    Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  113. ZHU K, Hunter M, James A, Lim EM, et al
    Discordance between fat mass index and body mass index is associated with reduced bone mineral density in women but not in men: the Busselton Healthy Ageing Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  114. LO JC, Kim S, Chandra M, Ettinger B, et al
    Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  115. GAO C, Qiao J, Li SS, Yu WJ, et al
    The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  116. KYVERNITAKIS I, Kostev K, Nassour T, Thomasius F, et al
    The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  117. BURR DB
    The use of finite element analysis to estimate the changing strength of bone following treatment for osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format    


  118. WARD J, Wood C, Rouch K, Pienkowski D, et al
    Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  119. MCCLOSKEY EV, Johansson H, Harvey NC, Compston J, et al
    Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  120. QIN W, Zhao W, Li X, Peng Y, et al
    Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  121. LEWIECKI EM, Boyle JF, Arora S, Bouchonville MF 2nd, et al
    Telementoring: a novel approach to reducing the osteoporosis treatment gap.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  122. WOZNIAK LA, Johnson JA, McAlister FA, Beaupre LA, et al
    Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  123. MORSE LR, Nguyen N, Battaglino RA, Guarino AJ, et al
    Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  124. MORAN JM, Pedrera-Zamorano JD
    Comments on: The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level.
    Osteoporos Int. 2016.
    PubMed     Text format    


  125. YUN BH, Seo SK
    Response to comments by Moran et al. on: The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level.
    Osteoporos Int. 2016.
    PubMed     Text format    


  126. WEAVER CM, Dawson-Hughes B, Lappe JM, Wallace TC, et al
    Erratum and additional analyses re: Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2016.
    PubMed     Text format    


  127. KJELLBERG J, Jorgensen AD, Vestergaard P, Ibsen R, et al
    Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  128. UGURLAR M
    Alendronate- and risedronate-induced acute polyarthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  129. LOU Y, Edmonds SW, Jones MP, Ullrich F, et al
    Predictors of bone mineral density testing among older women on Medicare.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  130. CHANG PY, Saechao FS, Lee J, Haskell SG, et al
    Prevalence and risk of fracture diagnoses in women across the adult life span: a national cross-sectional study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  131. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Predicting delayed union in osteoporotic vertebral fractures with consecutive magnetic resonance imaging in the acute phase: a multicenter cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  132. AKTAS I, Nazikoglu C, Kepez A, Ozkan FU, et al
    Effect of intravenous zoledronic acid infusion on electrocardiographic parameters in patients with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  133. MARQUES EA, Gudnason V, Lang T, Sigurdsson G, et al
    Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  134. YAGI M, Ohne H, Konomi T, Fujiyoshi K, et al
    Teriparatide improves volumetric bone mineral density and fine bone structure in the UIV+1 vertebra, and reduces bone failure type PJK after surgery for adult spinal deformity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  135. PEI YF, Xie ZG, Wang XY, Hu WZ, et al
    Association of 3q13.32 variants with hip trochanter and intertrochanter bone mineral density identified by a genome-wide association study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  136. PEREIRA RM, Figueiredo CP, Cha CC, Caparbo VF, et al
    Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  137. LUCATO P, Trevisan C, Stubbs B, Zanforlini BM, et al
    Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  138. BALASUBRAMANIAN A, Wade SW, Adler RA, Lin CJ, et al
    Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  139. ZHOU J, Ma X, Wang T, Zhai S, et al
    Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  140. AL-SARI UA, Tobias J, Clark E
    Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  141. YEH CB, Weng SJ, Chang KW, Chan JY, et al
    Calcitonin alleviates hyperalgesia in osteoporotic rats by modulating serotonin transporter activity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  142. BARZILAY JI, Buzkova P, Fink HA, Cauley JA, et al
    Systemic markers of microvascular disease and bone mineral density in older adults : The cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    May 2016
  143. ZHAO Y, Xue R, Shi N, Xue Y, et al
    Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  144. SHIRAKI M, Ueda S, Sugimoto T, Kuroda T, et al
    Treatment responses with once-weekly teriparatide therapy for osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  145. KONAK HE, Kibar S, Ergin ES
    The effect of single-task and dual-task balance exercise programs on balance performance in adults with osteoporosis: a randomized controlled preliminary trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  146. BETHEL M, Weaver FM, Bailey L, Miskevics S, et al
    Risk factors for osteoporotic fractures in persons with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  147. DENOVA-GUTIERREZ E, Clark P, Tucker KL, Munoz-Aguirre P, et al
    Dietary patterns are associated with bone mineral density in an urban Mexican adult population.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  148. WALKER MD, Saeed I, Lee JA, Zhang C, et al
    Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  149. IWANIEC UT, Philbrick KA, Wong CP, Gordon JL, et al
    Room temperature housing results in premature cancellous bone loss in growing female mice: implications for the mouse as a preclinical model for age-related bone loss.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  150. CHUNG SM, Hyun MH, Lee E, Seo HS, et al
    Novel effects of sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture: the national survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  151. HADJI P, Kyvernitakis I, Kann PH, Niedhart C, et al
    GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  152. HOPKINS RB, Burke N, Von Keyserlingk C, Leslie WD, et al
    The current economic burden of illness of osteoporosis in Canada.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  153. CUNNINGHAM TD, Martin BC, DeShields SC, Romero CC, et al
    The impact of osteoporotic fractures compared with other health conditions in older adults living in Virginia, United States.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  154. PENTON H, Hiligsmann M, Harrison M, Reginster JY, et al
    Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  155. CHOW SK, Leung KS, Qin J, Guo A, et al
    Mechanical stimulation enhanced estrogen receptor expression and callus formation in diaphyseal long bone fracture healing in ovariectomy-induced osteoporotic rats.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  156. SOLTANI S, Hunter GR, Kazemi A, Shab-Bidar S, et al
    The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  157. OLIVEIRA LC, Oliveira RG, Pires-Oliveira DA
    Effects of whole body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  158. YANG TC, Duthie GG, Aucott LS, Macdonald HM, et al
    Vitamin E homologues alpha- and gamma-tocopherol are not associated with bone turnover markers or bone mineral density in peri-menopausal and post-menopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  159. MCCLUNG MR
    Cancel the denosumab holiday.
    Osteoporos Int. 2016;27:1677-82.
    PubMed     Text format    


  160. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Osteoporos Int. 2016;27:1869-74.
    PubMed     Text format     Abstract available


  161. PAUPITZ JA, Lima GL, Alvarenga JC, Oliveira RM, et al
    Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.
    Osteoporos Int. 2016;27:1839-48.
    PubMed     Text format     Abstract available


    April 2016
  162. METZGER CE, Baek K, Swift SN, De Souza MJ, et al
    Exercise during energy restriction mitigates bone loss but not alterations in estrogen status or metabolic hormones.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  163. WARD LM, Konji VN, Ma J
    The management of osteoporosis in children.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  164. ZHAO G, Liu X, Li F
    Balloon kyphoplasty versus percutaneous vertebroplasty for treatment of osteoporotic vertebral compression fractures (OVCFs).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  165. BEAUDOIN C, Jean S, Bessette L, Ste-Marie LG, et al
    Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  166. SILVERMAN SL, Kupperman ES, Bukata SV
    Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  167. KIM YM, Kim SH, Kim S, Yoo JS, et al
    Variations in fat mass contribution to bone mineral density by gender, age, and body mass index: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  168. LESLIE WD, Majumdar SR, Lix LM, Josse RG, et al
    Direct comparison of FRAX and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  169. WANG FS, Lian WS, Weng WT, Sun YC, et al
    Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  170. YUN BH, Chon SJ, Choi YS, Cho S, et al
    The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  171. HILIGSMANN M, Ronda G, van der Weijden T, Boonen A, et al
    The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available



  172. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Committee of National Societies Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:579-84.
    PubMed     Text format    



  173. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Non-sponsored Symposia Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:555-77.
    PubMed     Text format    



  174. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Satellite Symposia Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:549-53.
    PubMed     Text format    



  175. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Poster Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:79-548.
    PubMed     Text format    



  176. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Meet-the-Expert Sessions.
    Osteoporos Int. 2016;27 Suppl 1:71-8.
    PubMed     Text format    



  177. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Educational Lecture Abstract.
    Osteoporos Int. 2016;27 Suppl 1:69.
    PubMed     Text format    



  178. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): ESCEO Symposia Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:63-8.
    PubMed     Text format    



  179. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Oral Communication Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:39-62.
    PubMed     Text format    



  180. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Plenary Lecture Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:33-7.
    PubMed     Text format    



  181. WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2016;27 Suppl 1:1-32.
    PubMed     Text format    


  182. TSENTIDIS C, Gourgiotis D, Kossiva L, Doulgeraki A, et al
    Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Osteoporos Int. 2016;27:1631-43.
    PubMed     Text format     Abstract available


  183. HOFFMAN V, Xue F, Gardstein B, Skerry K, et al
    Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.
    Osteoporos Int. 2016;27:1653-8.
    PubMed     Text format     Abstract available


  184. JACQUOT J, Delion M, Gangloff S, Braux J, et al
    Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.
    Osteoporos Int. 2016;27:1401-12.
    PubMed     Text format     Abstract available


    March 2016
  185. DROSSELMEYER J, Rapp MA, Hadji P, Kostev K, et al
    Depression risk in female patients with osteoporosis in primary care practices in Germany.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  186. CAVALIER E, Bergmann P, Bruyere O, Delanaye P, et al
    The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  187. BHAVSAR NV, Trivedi SR, Dulani K, Brahmbhatt N, et al
    Clinical and radiographic evaluation of effect of risedronate 5 mg as an adjunct to treatment of chronic periodontitis in postmenopausal women (12-month study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  188. FROST SA, Nguyen TV
    Uncertain effects of calcium and vitamin D supplementation on fracture risk reduction.
    Osteoporos Int. 2016.
    PubMed     Text format    


  189. EVSTIGNEEVA L, Lesnyak O, Bultink IE, Lems WF, et al
    Effect of twelve-month physical exercise program on patients with osteoporotic vertebral fractures: a randomized, controlled trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  190. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Erratum to: Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  191. ROUX JP, Belghali S, Wegrzyn J, Rendu ES, et al
    Vertebral body morphology is associated with incident lumbar vertebral fracture in postmenopausal women. The OFELY study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  192. LOOKER AC, Sarafrazi Isfahani N, Fan B, Shepherd JA, et al
    Trabecular bone scores and lumbar spine bone mineral density of US adults: comparison of relationships with demographic and body size variables.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  193. WEAVER CM, Gordon CM, Janz KF, Kalkwarf HJ, et al
    Erratum to: The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
    Osteoporos Int. 2016.
    PubMed     Text format    


  194. BUCKINX F, Reginster JY, Cavalier E, Petermans J, et al
    Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners.
    Osteoporos Int. 2016;27:881-6.
    PubMed     Text format     Abstract available


  195. MOSTI MP, Flemmen G, Hoff J, Stunes AK, et al
    Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment.
    Osteoporos Int. 2016;27:1003-10.
    PubMed     Text format     Abstract available


  196. ZHANG Y, Wang L, Song Y, Zhao X, et al
    Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
    Osteoporos Int. 2016;27:1083-92.
    PubMed     Text format     Abstract available


  197. DAMIAN LO, Simon SP, Filipescu I, Bocsa C, et al
    Capillaroscopic findings in a case of Hajdu-Cheney syndrome.
    Osteoporos Int. 2016;27:1269-73.
    PubMed     Text format     Abstract available


  198. DUDLEY-JAVOROSKI S, Petrie MA, McHenry CL, Amelon RE, et al
    Bone architecture adaptations after spinal cord injury: impact of long-term vibration of a constrained lower limb.
    Osteoporos Int. 2016;27:1149-60.
    PubMed     Text format     Abstract available


    February 2016
  199. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  200. HOPKINS SJ, Toms AD, Brown M, Welsman JR, et al
    A study investigating short- and medium-term effects on function, bone mineral density and lean tissue mass post-total knee replacement in a Caucasian female post-menopausal population: implications for hip fracture risk.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  201. LINDSAY R, Krege JH, Marin F, Jin L, et al
    Teriparatide for osteoporosis: importance of the full course.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  202. EL-HAJ M, Gurt I, Cohen-Kfir E, Dixit V, et al
    Reduced Sirtuin1 expression at the femoral neck in women who sustained an osteoporotic hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  203. ROSSINI M, Zanotti R, Orsolini G, Tripi G, et al
    Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  204. DELESKOG L, Laursen NO, Nielsen BR, Schwarz P, et al
    Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  205. LIM Y, Chun S, Lee JH, Baek KH, et al
    Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008-2011 Korea National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  206. RIZZOLI R, Benhamou CL, Halse J, Miller PD, et al
    Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  207. CHEN CH, Lin CL, Kao CH
    Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  208. WEAVER CM, Gordon CM, Janz KF, Kalkwarf HJ, et al
    The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  209. NORIEGA DC, Ramajo RH, Lite IS, Toribio B, et al
    Safety and clinical performance of kyphoplasty and SpineJack procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  210. BRUNETTI G, Papadia F, Tummolo A, Fischetto R, et al
    Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-alpha.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  211. LLOYD JT, Alley DE, Hochberg MC, Waldstein SR, et al
    Changes in bone mineral density over time by body mass index in the health ABC study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  212. GUARINO M, Loperto I, Camera S, Cossiga V, et al
    Osteoporosis across chronic liver disease.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  213. LAM FM, Bui M, Yang FZ, Pang MY, et al
    Chronic effects of stroke on hip bone density and tibial morphology: a longitudinal study.
    Osteoporos Int. 2016;27:591-603.
    PubMed     Text format     Abstract available


  214. VIAENE L, Behets GJ, Heye S, Claes K, et al
    Inflammation and the bone-vascular axis in end-stage renal disease.
    Osteoporos Int. 2016;27:489-97.
    PubMed     Text format     Abstract available


  215. HWANGBO Y, Kim JH, Kim SW, Park YJ, et al
    High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
    Osteoporos Int. 2016;27:457-62.
    PubMed     Text format     Abstract available


  216. KAWALILAK CE, Johnston JD, Cooper DM, Olszynski WP, et al
    Role of endocortical contouring methods on precision of HR-pQCT-derived cortical micro-architecture in postmenopausal women and young adults.
    Osteoporos Int. 2016;27:789-96.
    PubMed     Text format     Abstract available


  217. KHEIR V, Munier FL, Aubry-Rozier B, Schorderet DF, et al
    Potential blindness in children of patients with hereditary bone disease.
    Osteoporos Int. 2016;27:841-4.
    PubMed     Text format     Abstract available


  218. TAN J, Fu X, Sun CG, Liu C, et al
    A single CT-guided percutaneous intraosseous injection of thermosensitive simvastatin/poloxamer 407 hydrogel enhances vertebral bone formation in ovariectomized minipigs.
    Osteoporos Int. 2016;27:757-67.
    PubMed     Text format     Abstract available


    January 2016
  219. SI L, Winzenberg TM, Chen M, Jiang Q, et al
    Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  220. DOU C, Chen Y, Ding N, Li N, et al
    Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  221. PEDERSEN AB, Baggesen LM, Ehrenstein V, Pedersen L, et al
    Perceived stress and risk of any osteoporotic fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  222. MUSUMECI M, Palermo A, D'Onofrio L, Vadala G, et al
    Erratum to: Serum chitotriosidase in postmenopausal women with severe osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format    


  223. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  224. KATZMAN WB, Vittinghoff E, Kado DM, Lane NE, et al
    Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention Trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  225. LEE JH, Lee YK, Oh SH, Ahn J, et al
    A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  226. DREW S, Judge A, Cooper C, Javaid MK, et al
    Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  227. WANG X, Yan S, Liu C, Xu Y, et al
    Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  228. ZHANG ZQ, Cao WT, Liu J, Cao Y, et al
    Greater serum carotenoid concentration associated with higher bone mineral density in Chinese adults.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  229. ZHENG Y, Wang C, Zhang H, Shao C, et al
    Polymorphisms in Wnt signaling pathway genes are associated with peak bone mineral density, lean mass, and fat mass in Chinese male nuclear families.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  230. WANG J, Yao M, Xu JH, Shu B, et al
    Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  231. LI M, Lv F, Zhang Z, Deng W, et al
    Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  232. LESLIE WD, Schousboe JT, Lix LM
    Towards better use of the net reclassification improvement (NRI) index.
    Osteoporos Int. 2016;27:411-2.
    PubMed     Text format    


  233. NAYLOR KE, Jacques RM, Paggiosi M, Gossiel F, et al
    Bone turnover markers: response to comments by Seeman and Nguyen.
    Osteoporos Int. 2016;27:37.
    PubMed     Text format    


  234. LEIB ES, Winzenrieth R
    Bone status in glucocorticoid-treated men and women.
    Osteoporos Int. 2016;27:39-48.
    PubMed     Text format     Abstract available


  235. MATUTE-LLORENTE A, Gonzalez-Aguero A, Gomez-Cabello A, Tous-Fajardo J, et al
    Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial.
    Osteoporos Int. 2016;27:181-91.
    PubMed     Text format     Abstract available


  236. EASTELL R, Dijk DJ, Small M, Greenwood A, et al
    Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial.
    Osteoporos Int. 2016;27:309-18.
    PubMed     Text format     Abstract available


    December 2015
  237. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  238. POPP AW, Zysset PK, Lippuner K
    Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  239. CHEN JS, Hill CL, Lester S, Ruediger CD, et al
    Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  240. COLOMA PM, de Ridder M, Bezemer I, Herings RM, et al
    Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  241. ANASTASILAKIS AD, Makras P
    Multiple clinical vertebral fractures following denosumab discontinuation.
    Osteoporos Int. 2015.
    PubMed     Text format    


  242. SILVERMAN SL, Adachi JD, Dennison E
    Bisphosphonate drug holidays: we reap what we sow.
    Osteoporos Int. 2015.
    PubMed     Text format    


  243. SVENSSON HK, Olofsson EH, Karlsson J, Hansson T, et al
    A painful, never ending story: older women's experiences of living with an osteoporotic vertebral compression fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  244. KLASSEN KM, Kimlin MG, Fairley CK, Emery S, et al
    Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  245. BETHEL M, Buzkova P, Fink HA, Robbins JA, et al
    Soluble CD14 and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  246. FREITAS PM, Garcia Rosa ML, Gomes AM, Wahrlich V, et al
    Central and peripheral fat body mass have a protective effect on osteopenia or osteoporosis in adults and elderly?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  247. OIKONOMIDOU PR, Casu C, Yang Z, Crielaard B, et al
    Polycythemia is associated with bone loss and reduced osteoblast activity in mice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  248. NAKAYAMA A, Major G, Holliday E, Attia J, et al
    Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  249. XU LH, Adams-Huet B, Poindexter JR, Maalouf NM, et al
    Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  250. MODI A, Sen S, Adachi JD, Adami S, et al
    Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  251. BOURS S, de Vries F, van den Bergh JP, Lalmohamed A, et al
    Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  252. RUDANG R, Zoulakis M, Sundh D, Brisby H, et al
    Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  253. PENONI DC, Torres SR, Farias ML, Fernandes TM, et al
    Association of osteoporosis and bone medication with the periodontal condition in elderly women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available



  254. IOF Regionals - 3rd Middle East & Africa Osteoporosis Meeting : Poster Presentation Abstracts.
    Osteoporos Int. 2015;26 Suppl 2:439-86.
    PubMed     Text format    



  255. IOF Regionals - 3rd Middle East & Africa Osteoporosis Meeting : Oral Communication Abstracts.
    Osteoporos Int. 2015;26 Suppl 2:427-37.
    PubMed     Text format    



  256. IOF Regionals - 3rd Middle East & Africa Osteoporosis Meeting : Plenary Lecture Abstracts.
    Osteoporos Int. 2015;26 Suppl 2:421-5.
    PubMed     Text format    


    November 2015
  257. ZHOU B, Huang Y, Li H, Sun W, et al
    Proton pump inhibitors and fracture risk: response to comments.
    Osteoporos Int. 2015.
    PubMed     Text format    


  258. KUIPERS AL, Miljkovic I, Evans R, Bunker CH, et al
    Optimal serum cholesterol concentrations are associated with accelerated bone loss in African ancestry men.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  259. SENAY A, Delisle J, Raynauld JP, Morin SN, et al
    Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone program.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  260. BROZEK W, Reichardt B, Zwerina J, Dimai HP, et al
    Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  261. MARCINIAK C, Gabet J, Lee J, Ma M, et al
    Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  262. MA C, Shuai B, Shen L, Yang YP, et al
    Serum carcinoembryonic antigen-related cell adhesion molecule 1 level in postmenopausal women: correlation with beta-catenin and bone mineral density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  263. AVILA ML, Pullenayegum E, Williams S, Shammas A, et al
    Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  264. MCCLOSKEY E
    A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base.
    Osteoporos Int. 2015.
    PubMed     Text format    


  265. UZOIGWE CE
    The real enemy is fragility fracture, not osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  266. CLARK EM, Gooberman-Hill R, Peters TJ
    Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  267. LI Y, Zhou J, Wu Y, Lu T, et al
    Association of osteoporosis with genetic variants of circadian genes in Chinese geriatrics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  268. KARJALAINEN JP, Riekkinen O, Toyras J, Jurvelin JS, et al
    New method for point-of-care osteoporosis screening and diagnostics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  269. COSMAN F, Gilchrist N, McClung M, Foldes J, et al
    A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  270. CHEN F, Dai Z, Kang Y, Lv G, et al
    Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  271. FARSINEJAD-MARJ M, Saneei P, Esmaillzadeh A
    Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  272. MURRAY JC, Audet MC, Bedard M, Michou L, et al
    Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  273. SUGIYAMA T, Torio T, Miyajima T, Kim YT, et al
    Calcium, proton pump inhibitors, and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format    


  274. RUD B, Vestergaard A, Hyldstrup L
    Accuracy of densitometric vertebral fracture assessment when performed by DXA technicians-a cross-sectional, multiobserver study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  275. BEALL DP, Feldman RG, Gordon ML, Gruber BL, et al
    Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  276. SUMIDA K, Ubara Y, Hoshino J, Mise K, et al
    Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  277. JACOB L, Dreher M, Kostev K, Hadji P, et al
    Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  278. SATO H, Kondo N, Wada Y, Nakatsue T, et al
    The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  279. WEAVER CM, Alexander DD, Boushey CJ, Dawson-Hughes B, et al
    Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  280. DARUWALLA ZJ, Huq SS, Wong KL, Nee PY, et al
    Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  281. SANTI D, Madeo B, Carli F, Zona S, et al
    Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  282. AUBRY-ROZIER B, Gonzalez-Rodriguez E, Stoll D, Lamy O, et al
    Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  283. SELGA J, Nunez JH, Minguell J, Lalanza M, et al
    Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  284. HOLM JP, Amar AO, Hyldstrup L, Jensen JE, et al
    Hyponatremia, a risk factor for osteoporosis and fractures in women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  285. SUGIYAMA T, Kim YT, Oda H
    Both falling and bone fragility should be targeted to prevent hip fracture in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format    


  286. EARLY C, Stuckey L, Tischer S
    Osteoporosis in the adult solid organ transplant population: underlying mechanisms and available treatment options.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  287. EBINA K, Noguchi T, Hirao M, Hashimoto J, et al
    Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  288. WEN Y, Guo X, Hao J, Xiao X, et al
    Integrative analysis of genome-wide association studies and gene expression profiles identified candidate genes for osteoporosis in Kashin-Beck disease patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  289. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  290. RAMCHAND SK, Chiang CY, Zebaze RM, Seeman E, et al
    Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  291. SOLOMON DH, Ruppert K, Zhao Z, Lian YJ, et al
    Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  292. WANG Q, Huang Q, Zeng Y, Liang JJ, et al
    Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  293. EIKEN P, Vestergaard P
    Treatment of osteoporosis after alendronate or risedronate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  294. DONNER DG, Elliott GE, Beck BR, Forwood MR, et al
    The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  295. HOLLOWAY KL, Henry MJ, Brennan-Olsen SL, Bucki-Smith G, et al
    Non-hip and non-vertebral fractures: the neglected fracture sites.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    September 2015
  296. GIFRE L, Vidal J, Carrasco JL, Muxi A, et al
    Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  297. HEGDE V, Jo JE, Andreopoulou P, Lane JM, et al
    Effect of osteoporosis medications on fracture healing.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  298. LEE SJ, Binkley N, Lubner MG, Bruce RJ, et al
    Opportunistic screening for osteoporosis using the sagittal reconstruction from routine abdominal CT for combined assessment of vertebral fractures and density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  299. LUO D, Ren H, Li T, Lian K, et al
    Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  300. ETHGEN O, Hiligsmann M, Burlet N, Reginster JY, et al
    Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  301. ALARCON T, Gonzalez-Montalvo JI, Martin-Vega A, Gotor P, et al
    Improving persistence and adherence to osteoporosis treatment: a challenge to solve.
    Osteoporos Int. 2015.
    PubMed     Text format    


  302. YAO W, Dai W, Jiang L, Lay EY, et al
    Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  303. ZHANG ZL, Liao EY, Xia WB, Lin H, et al
    Erratum to: Alendronate sodium/vitamin D combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension.
    Osteoporos Int. 2015.
    PubMed     Text format    


  304. HWANG IR, Choi YK, Lee WK, Kim JG, et al
    Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  305. YUAN HF, Guo CA, Yan ZQ
    The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  306. LUO Y
    A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  307. BONE HG, Dempster DW, Eisman JA, Greenspan SL, et al
    Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.
    Osteoporos Int. 2015.
    PubMed     Text format    


  308. JEMIELITA TO, Leonard MB, Baker J, Sayed S, et al
    Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  309. FRITZ J, Coster ME, Nilsson JA, Rosengren BE, et al
    The associations of physical activity with fracture risk-a 7-year prospective controlled intervention study in 3534 children.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  310. SHIN J, Sung J, Lee K, Song YM, et al
    Genetic influence on the association between bone mineral density and testosterone in Korean men.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  311. CARBONE S, Papalia M
    The amount of impaction and loss of reduction in osteoporotic proximal humeral fractures after surgical fixation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  312. JURIMAE J, Tillmann V, Cicchella A, Stefanelli C, et al
    Increased sclerostin and preadipocyte factor-1 levels in prepubertal rhythmic gymnasts: associations with bone mineral density, body composition, and adipocytokine values.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  313. KRISHNAMOORTHY D, Frechette DM, Adler BJ, Green DE, et al
    Marrow adipogenesis and bone loss that parallels estrogen deficiency is slowed by low-intensity mechanical signals.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    August 2015
  314. THORIN MH, Wihlborg A, Akesson K, Gerdhem P, et al
    Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  315. EDWARDS BJ, Gradishar WJ, Smith ME, Pacheco JA, et al
    Elevated incidence of fractures in women with invasive breast cancer.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  316. MOON RJ, Lim A, Farmer M, Segaran A, et al
    Validity of parental recall of children's fracture: implications for investigation of childhood osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  317. CLARK EM, Gould VC, Tobias JH, Horne R, et al
    Natural history, reasons for, and impact of low/non-adherence to medications for osteoporosis in a cohort of community-dwelling older women already established on medication: a 2-year follow-up study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  318. HOLZMUELLER CG, Karp S, Zeldow D, Lee DB, et al
    Development of a cloud-based application for the Fracture Liaison Service model of care.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  319. KARLSSON L, Lundkvist J, Psachoulia E, Intorcia M, et al
    Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  320. YONG JH, Masucci L, Hoch JS, Sujic R, et al
    Cost-effectiveness of a fracture liaison service-a real-world evaluation after 6 years of service provision.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  321. FECHTENBAUM J, Etcheto A, Kolta S, Feydy A, et al
    Sagittal balance of the spine in patients with osteoporotic vertebral fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  322. HU S, Liu CC, Chen G, Willett T, et al
    In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  323. BARZILAY JI, Buzkova P, Kizer JR, Djousse L, et al
    Fibrosis markers, hip fracture risk, and bone density in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  324. SACHELARIE L, Farcas DM, Dartu L, Vasiliu M, et al
    Comparative study of diseases of the stomatognathic system and specific parameters of osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  325. DUMIC M, Putarek NR, Kusec V, Barisic N, et al
    Low bone mineral density for age/osteoporosis in triple A syndrome-an overlooked symptom of unexplained etiology.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  326. IWATA T, Ito H, Furu M, Hashimoto M, et al
    Periarticular osteoporosis of the forearm correlated with joint destruction and functional impairment in patients with rheumatoid arthritis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  327. MUSUMECI M, Palermo A, D'Onofrio L, Vadala G, et al
    Serum chitotriosidase in postmenopausal women with severe osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  328. HE H, Liu Y, Tian Q, Papasian CJ, et al
    Relationship of sarcopenia and body composition with osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  329. CHANG CY, Tang CH, Chen KC, Huang KC, et al
    The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  330. LESLIE WD, Brennan-Olsen SL, Morin SN, Lix LM, et al
    Fracture prediction from repeat BMD measurements in clinical practice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    July 2015
  331. YAN Z, Huang H, Li J, Wang J, et al
    Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  332. LIU Z, Weaver J, de Papp A, Li Z, et al
    Disparities in osteoporosis treatments.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  333. HA KY, Park KS, Kim SI, Kim YH, et al
    Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  334. PAPAPOULOS S, Lippuner K, Roux C, Lin CJ, et al
    The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  335. GILLETTE C, Howerton DM, Williams BD, Mahmood MA, et al
    Medication persistence in older women with osteoporosis: a pilot study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  336. ZHUKOUSKAYA VV, Eller-Vainicher C, Gaudio A, Privitera F, et al
    Erratum to: The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format    


  337. LING Y, Gao X, Lin H, Ma H, et al
    A common polymorphism rs1800247 in osteocalcin gene was associated with serum osteocalcin levels, bone mineral density, and fracture: the Shanghai Changfeng Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  338. SILVERMAN SL, Wang A, Cheng L, Yang Y, et al
    Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  339. NOORAFSHAN A, Dabbaghmanesh MH, Tanideh N, Koohpeyma F, et al
    Stereological study of the effect of black olive hydroalcoholic extract on osteoporosis in vertebra and tibia in ovariectomized rats.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  340. PICKHARDT PJ, Lauder T, Pooler BD, Munoz Del Rio A, et al
    Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  341. ALBAUM JM, Levesque LE, Gershon AS, Liu G, et al
    Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  342. ZHUKOUSKAYA VV, Vainicher CE, Gaudio A, Privitera F, et al
    The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  343. COMPSTON J
    Overdiagnosis of osteoporosis: fact or fallacy?
    Osteoporos Int. 2015.
    PubMed     Text format    


  344. LIU W, Wang T, Yang C, Darvell BW, et al
    Alkaline biodegradable implants for osteoporotic bone defects-importance of microenvironment pH.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  345. OLMOS JM, Hernandez JL, Garcia-Velasco P, Martinez J, et al
    Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  346. WANG CY, Fu SH, Wang CL, Chen PJ, et al
    Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    June 2015
  347. AMOUZOUGAN A, Deygat A, Trombert B, Constant E, et al
    Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  348. TIAN FM, Yang K, Wang WY, Luo Y, et al
    Calcitonin suppresses intervertebral disk degeneration and preserves lumbar vertebral bone mineral density and bone strength in ovariectomized rats.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  349. YOSHIGA D, Sasaguri M, Matsuo K, Kokuryou S, et al
    Erratum to: Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
    Osteoporos Int. 2015.
    PubMed     Text format    


  350. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Erratum to: Analysis of daily teriparatide treatment for osteoporosis in men.
    Osteoporos Int. 2015.
    PubMed     Text format    


  351. HARVEY NC, Kanis JA, Oden A, Burge RT, et al
    FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  352. HERNANDEZ I, Pinera A
    Incidence of fracture events with teriparatide: role of study design.
    Osteoporos Int. 2015.
    PubMed     Text format    


  353. HARVEY NC, Kanis JA, Oden A, Nakamura T, et al
    Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  354. D'AMELIO P, Sassi F, Buondonno I, Fornelli G, et al
    Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  355. FERRARI S, Adachi JD, Lippuner K, Zapalowski C, et al
    Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  356. ZHANG C, Ma J, Chen G, Fu D, et al
    Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  357. BRIOT K, Fechtenbaum J, Etcheto A, Kolta S, et al
    Diagnosis of vertebral fractures using a low-dose biplanar imaging system.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  358. GUO Z, Yang J, Zheng Y, Wang Y, et al
    Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study.
    Osteoporos Int. 2015.
    PubMed     Text format    


  359. NARANJO A, Ojeda-Bruno S, Bilbao-Cantarero A, Quevedo-Abeledo JC, et al
    Two-year adherence to treatment and associated factors in a fracture liaison service in Spain.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  360. YAN Y, Zou T, Xu R
    Reply to "Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study".
    Osteoporos Int. 2015.
    PubMed     Text format    


  361. YOSHIGA D, Sasaguri M, Matsuo K, Kokuryou S, et al
    Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    May 2015
  362. HADJI P, Papaioannou N, Gielen E, Feudjo Tepie M, et al
    Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  363. NAKAMURA T, Ito M, Hashimoto J, Shinomiya K, et al
    Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  364. CROCKETT K, Arnold CM, Farthing JP, Chilibeck PD, et al
    Bone strength and muscle properties in postmenopausal women with and without a recent distal radius fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  365. SANGTARASH F, Manshadi FD, Sadeghi A
    The relationship of thoracic kyphosis to gait performance and quality of life in women with osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  366. MATUTE-LLORENTE A, Gonzalez-Aguero A, Gomez-Cabello A, Olmedillas H, et al
    Effect of whole body vibration training on bone mineral density and bone quality in adolescents with Down syndrome: a randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  367. NAYLOR KE, Jacques RM, Paggiosi M, Gossiel F, et al
    Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  368. WU CT, Yang YH, Chen PC, Chen MF, et al
    Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  369. TIAN Y, Shen L, Wu J, Xu G, et al
    Sleep duration and timing in relation to osteoporosis in an elderly Chinese population: a cross-sectional analysis in the Dongfeng-Tongji cohort study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  370. MARQUES A, Lourenco O, da Silva JA
    The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  371. COSMAN F, de Beur SJ, LeBoff MS, Lewiecki EM, et al
    Erratum to: Clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  372. TSUKUTANI Y, Hagino H, Ito Y, Nagashima H, et al
    Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  373. WANG O, Hu Y, Gong S, Xue Q, et al
    A survey of outcomes and management of patients post fragility fractures in China.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  374. KEMMLER W, Bebenek M, Kohl M, von Stengel S, et al
    Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS).
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  375. MIYAKOSHI N, Hongo M, Kobayashi T, Abe T, et al
    Improvement of spinal alignment and quality of life after corrective surgery for spinal kyphosis in patients with osteoporosis: a comparative study with non-operated patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  376. KLOP C, Gibson-Smith D, Elders PJ, Welsing PM, et al
    Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  377. XIN M, Yang Y, Zhang D, Wang J, et al
    Attenuation of hind-limb suspension-induced bone loss by curcumin is associated with reduced oxidative stress and increased vitamin D receptor expression.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  378. FERLIN A, Selice R, Di Mambro A, Ghezzi M, et al
    Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  379. YOUN JC, Lee SJ, Lee HS, Oh J, et al
    Exercise capacity independently predicts bone mineral density and proximal femoral geometry in patients with acute decompensated heart failure.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  380. HOOVER KB, Miller CG, Galante NC, Langman CB, et al
    A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  381. CIZMIC AD, Heilmann RM, Milchak JL, Riggs CS, et al
    Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  382. CHEN L, Wang G, Zheng F, Zhao H, et al
    Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  383. GIFRE L, Vidal J, Carrasco JL, Muxi A, et al
    Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  384. KOVACS CS, Ralston SH
    Presentation and management of osteoporosis presenting in association with pregnancy or lactation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  385. ZHANG ZL, Liao EY, Xia WB, Lin H, et al
    Alendronate sodium/vitamin D combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  386. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Cortisol and the muscle-bone axis: response to comments by Molfino et al.
    Osteoporos Int. 2015;26:1661-2.
    PubMed     Text format    


  387. BURDEN AM, Tadrous M, Calzavara A, Cadarette SM, et al
    Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary access.
    Osteoporos Int. 2015;26:1525-33.
    PubMed     Text format     Abstract available


  388. BINKLEY N, Lappe J, Singh RJ, Khosla S, et al
    Can vitamin D metabolite measurements facilitate a "treat-to-target" paradigm to guide vitamin D supplementation?
    Osteoporos Int. 2015;26:1655-60.
    PubMed     Text format     Abstract available


    April 2015
  389. LIPHARDT AM, Schipilow JD, Macdonald HM, Kan M, et al
    Bone micro-architecture of elite alpine skiers is not reflected by bone mineral density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  390. PALERMO A, D'Onofrio L, Eastell R, Schwartz AV, et al
    Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  391. VELDHUIS-VLUG AG, Oei L, Souverein PC, Tanck MW, et al
    Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  392. KIM YA, Kim KM, Lim S, Choi SH, et al
    Favorable effect of dietary vitamin C on bone mineral density in postmenopausal women (KNHANES IV, 2009): discrepancies regarding skeletal sites, age, and vitamin D status.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  393. PACCOU J, Edwards MH, Ward KA, Jameson KA, et al
    Ischemic heart disease is associated with lower cortical volumetric bone mineral density of distal radius.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  394. KREGE JH, Burge RT, Marin F
    Teriparatide fracture effectiveness in the real world.
    Osteoporos Int. 2015.
    PubMed     Text format    


  395. BARRETT-CONNOR E, Wade SW, Downs RW, Ganiats T, et al
    Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  396. AHMED LA, Shigdel R, Joakimsen RM, Eldevik OP, et al
    Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  397. REGINSTER JY, Brandi ML, Cannata-Andia J, Cooper C, et al
    The position of strontium ranelate in today's management of osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  398. MONADI M, Javadian Y, Cheraghi M, Heidari B, et al
    Impact of treatment with inhaled corticosteroids on bone mineral density of patients with asthma: related with age.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  399. VAN DEN BERG P, Schweitzer DH, van Haard PM, van den Bergh JP, et al
    Meeting international standards of secondary fracture prevention: a survey on Fracture Liaison Services in the Netherlands.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  400. TERZI R, Ozer T
    A tuber calcanei avulsion fracture developed on the basis of idiopathic osteoporosis in a young male: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  401. BIVER E, Durosier C, Chevalley T, Herrmann FR, et al
    Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  402. LOVY AJ, Koehler SM, Keswani A, Joseph D, et al
    Atypical femur fracture during bisphosphonate drug holiday: a case series.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  403. WIHLBORG A, Englund M, Akesson K, Gerdhem P, et al
    Fracture predictive ability of physical performance tests and history of falls in elderly women: a 10-year prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  404. EBINA K, Hashimoto J, Shi K, Kashii M, et al
    Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda.
    Osteoporos Int. 2015;26:1445.
    PubMed     Text format    


  405. MOKUDA S
    Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in rheumatoid arthritis patients.
    Osteoporos Int. 2015;26:1443.
    PubMed     Text format    


  406. MURAI IH, Roschel H, Pabis LV, Takayama L, et al
    Exercise training, creatine supplementation, and bone health in ovariectomized rats.
    Osteoporos Int. 2015;26:1395-404.
    PubMed     Text format     Abstract available


  407. CESAREO R, Di Stasio E, Vescini F, Campagna G, et al
    Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
    Osteoporos Int. 2015;26:1295-302.
    PubMed     Text format     Abstract available


    March 2015
  408. KLOP C, Welsing PM, Elders PJ, Overbeek JA, et al
    Long-term persistence with anti-osteoporosis drugs after fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  409. AFSHINNIA F, Sundaram B, Ackermann RJ, Wong KK, et al
    Hyponatremia and osteoporosis: reappraisal of a novel association.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  410. ITO K, Leslie WD
    Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  411. YANG S, Center JR, Eisman JA, Nguyen TV, et al
    Erratum to: Association between fat mass, lean mass, and bone loss: the Dubbo osteoporosis epidemiology study.
    Osteoporos Int. 2015.
    PubMed     Text format    


  412. ABIMANYI-OCHOM J, Watts JJ, Borgstrom F, Nicholson GC, et al
    Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS).
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  413. CLAESSON A, Toth-Pal E, Piispanen P, Salminen H, et al
    District nurses' perceptions of osteoporosis management: a qualitative study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  414. GREENSPAN SL, Vujevich KT, Brufsky A, Lembersky BC, et al
    Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  415. BABA T, Hagino H, Nonomiya H, Ikuta T, et al
    Inadequate management for secondary fracture prevention in patients with distal radius fracture by trauma surgeons.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  416. SI L, Winzenberg TM, Jiang Q, Chen M, et al
    Projection of osteoporosis-related fractures and costs in China: 2010-2050.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  417. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Trabecular bone score may improve FRAX(R) prediction accuracy for major osteoporotic fractures in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  418. HANDS B, Chivers P, McIntyre F, Bervenotti FC, et al
    Peripheral quantitative computed tomography (pQCT) reveals low bone mineral density in adolescents with motor difficulties.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  419. HERRERA L, Leal I, Lapi F, Schuemie M, et al
    Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  420. DUECK AC, Singh J, Atherton P, Liu H, et al
    Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  421. MAKRAS P, Athanasakis K, Boubouchairopoulou N, Rizou S, et al
    Cost-effective osteoporosis treatment thresholds in Greece.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  422. QIU Y, Yao J, Wu X, Zhou B, et al
    Longitudinal assessment of oxytocin efficacy on bone and bone marrow fat masses in a rabbit osteoporosis model through 3.0-T magnetic resonance spectroscopy and micro-CT.
    Osteoporos Int. 2015;26:1081-92.
    PubMed     Text format     Abstract available


  423. DAMJI AN, Bies K, Alibhai SM, Jones JM, et al
    Bone health management in men undergoing ADT: examining enablers and barriers to care.
    Osteoporos Int. 2015;26:951-9.
    PubMed     Text format     Abstract available


  424. BORON D, Kaminski A, Kotrych D, Bogacz A, et al
    Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.
    Osteoporos Int. 2015;26:1045-52.
    PubMed     Text format     Abstract available


  425. KRAUSE M, Keller J, Beil B, van Driel I, et al
    Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.
    Osteoporos Int. 2015;26:987-95.
    PubMed     Text format     Abstract available


    February 2015
  426. VAROL E
    The relationship between platelet indices and postmenopausal osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  427. MCCLOSKEY EV, Kanis JA, Oden A, Harvey NC, et al
    Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  428. CHEN Z, Salam MT, Karim R, Toledo-Corral CM, et al
    Living near a freeway is associated with lower bone mineral density among Mexican Americans.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  429. SAKAI A, Ito M, Tomomitsu T, Tsurukami H, et al
    Erratum to: Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  430. NAYAK S, Edwards DL, Saleh AA, Greenspan SL, et al
    Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available



  431. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): Committee of National Societies Abstracts.
    Osteoporos Int. 2015;26 Suppl 1:397-401.
    PubMed     Text format    



  432. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): Non-sponsored Symposia Abstracts.
    Osteoporos Int. 2015;26 Suppl 1:387-96.
    PubMed     Text format    



  433. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): Satellite Symposia Abstracts.
    Osteoporos Int. 2015;26 Suppl 1:381-6.
    PubMed     Text format    



  434. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): Poster Abstracts.
    Osteoporos Int. 2015;26 Suppl 1:71-380.
    PubMed     Text format    



  435. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): Meet-the-Expert Sessions.
    Osteoporos Int. 2015;26 Suppl 1:65-9.
    PubMed     Text format    



  436. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): IOF Abstracts.
    Osteoporos Int. 2015;26 Suppl 1:63-4.
    PubMed     Text format    



  437. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): ESCEO Symposia Abstracts.
    Osteoporos Int. 2015;26 Suppl 1:57-62.
    PubMed     Text format    



  438. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): Oral Communication Abstracts.
    Osteoporos Int. 2015;26 Suppl 1:35-56.
    PubMed     Text format    



  439. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): Plenary Lecture Abstracts.
    Osteoporos Int. 2015;26 Suppl 1:29-33.
    PubMed     Text format    


  440. RASCH LA, van Tuyl LH, de van der Schueren MA, Bultink IE, et al
    Estimation of dietary calcium intake.
    Osteoporos Int. 2015;26:835-6.
    PubMed     Text format    


  441. MACDONALD HM, Black AJ
    Validation of a short questionnaire for estimating dietary calcium intakes.
    Osteoporos Int. 2015;26:837.
    PubMed     Text format    


  442. LAI CC, Chen WS, Chang DM, Tsao YP, et al
    Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.
    Osteoporos Int. 2015;26:601-10.
    PubMed     Text format     Abstract available


    January 2015
  443. BREITLING LP
    Calcium intake and bone mineral density as an example of non-linearity and threshold analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  444. THOMSEN K, Jepsen DB, Matzen L, Hermann AP, et al
    Is calcaneal quantitative ultrasound useful as a prescreen stratification tool for osteoporosis?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  445. DAVIS SR, Tan A, Bell RJ
    Targeted assessment of fracture risk in women at midlife.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  446. SATO Y, Iki M, Fujita Y, Tamaki J, et al
    Greater milk intake is associated with lower bone turnover, higher bone density, and higher bone microarchitecture index in a population of elderly Japanese men with relatively low dietary calcium intake: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN)
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  447. HUNG VW, Zhu TY, Cheung WH, Fong TN, et al
    Age-related differences in volumetric bone mineral density, microarchitecture, and bone strength of distal radius and tibia in Chinese women: a high-resolution pQCT reference database study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  448. FORIEN M, Molto A, Etcheto A, Dougados M, et al
    Bone mineral density in patients with symptoms suggestive of spondyloarthritis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  449. BIANCHI ML, Duca P, Vai S, Guglielmi G, et al
    Improving adherence to and persistence with oral therapy of osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  450. BAEK SW, Kim C, Chang H
    The relationship between the spinopelvic balance and the incidence of adjacent vertebral fractures following percutaneous vertebroplasty.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  451. MANTHRIPRAGADA AD, O'Malley CD, Gruntmanis U, Hall JW, et al
    Fracture incidence in a large cohort of men age 30 years and older with osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  452. MONTALCINI T, Gallotti P, Coppola A, Zambianchi V, et al
    Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  453. OYEN J, Svingen GF, Gjesdal CG, Tell GS, et al
    Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  454. BANSAL S, Pecina JL, Merry SP, Kennel KA, et al
    US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  455. BONFA AC, Seguro LP, Caparbo V, Bonfa E, et al
    RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  456. MCCLUNG MR
    Bisphosphonate therapy: how long is long enough?
    Osteoporos Int. 2015.
    PubMed     Text format    


  457. ZHAO R, Zhao M, Xu Z
    The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  458. OVERMAN RA, Gourlay ML, Deal CL, Farley JF, et al
    Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  459. MACHADO KL, Domiciano DS, Machado LG, Lopes JB, et al
    Persistent hypovitaminosis D and loss of hip bone mineral density over time as additional risk factors for recurrent falls in a population-based prospective cohort of elderly persons living in the community. The Sao Paulo Ageing & Health (SPAH) St
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  460. BLIUC D, Nguyen ND, Alarkawi D, Nguyen TV, et al
    Accelerated bone loss and increased post-fracture mortality in elderly women and men.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  461. LEE SY, Kwon SS, Kim HS, Yoo JH, et al
    Reliability and validity of lower extremity computed tomography as a screening tool for osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  462. SAKAI A, Ito M, Tomomitsu T, Tsurukami H, et al
    Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  463. YANG S, Center JR, Eisman JA, Nguyen TV, et al
    Association between fat mass, lean mass, and bone loss: the Dubbo osteoporosis epidemiology study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  464. BENZINGER P, Rapp K, Konig HH, Bleibler F, et al
    Risk of osteoporotic fractures following stroke in older persons.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  465. BRENNAN SL, Holloway KL, Williams LJ, Kotowicz MA, et al
    The social gradient of fractures at any skeletal site in men and women: data from the Geelong Osteoporosis Study Fracture Grid.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  466. JUGDAOHSINGH R, Watson AI, Bhattacharya P, van Lenthe GH, et al
    Positive association between serum silicon levels and bone mineral density in female rats following oral silicon supplementation with monomethylsilanetriol.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  467. MOLVIK H, Khan W
    Bisphosphonates and their influence on fracture healing: a systematic review.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  468. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Analysis of daily teriparatide treatment for osteoporosis in men.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  469. SI L, Winzenberg TM, Jiang Q, Palmer AJ, et al
    Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  470. BONAFEDE MM, Shi N, Bower AG, Barron RL, et al
    Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  471. LOOKER AC
    Dysmobility syndrome and mortality risk in US men and women age 50 years and older.
    Osteoporos Int. 2015;26:93-102.
    PubMed     Text format     Abstract available


  472. KALLURU R, Ames R, Mason B, Bolland MJ, et al
    Bone density in healthy men after cessation of calcium supplements: 20-month follow-up of a randomized controlled trial.
    Osteoporos Int. 2015;26:173-8.
    PubMed     Text format     Abstract available


  473. YOSHIMURA N, Muraki S, Oka H, Nakamura K, et al
    Serum levels of 25-hydroxyvitamin D and the occurrence of musculoskeletal diseases: a 3-year follow-up to the road study.
    Osteoporos Int. 2015;26:151-61.
    PubMed     Text format     Abstract available


  474. RIZZOLI R, Sigaud A, Azria M, Herrmann FR, et al
    Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.
    Osteoporos Int. 2015;26:383-93.
    PubMed     Text format     Abstract available


  475. STUCKEY BG, Sallie R
    Alendronate-induced unmasking or deterioration of coeliac disease: a case series.
    Osteoporos Int. 2015;26:411-4.
    PubMed     Text format    


  476. SILVERMAN S, Curtis J, Saag K, Flahive J, et al
    International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.
    Osteoporos Int. 2015;26:419-20.
    PubMed     Text format    


  477. CHATTERJEE M, Hatori K, Duyck J, Sasaki K, et al
    High-frequency loading positively impacts titanium implant osseointegration in impaired bone.
    Osteoporos Int. 2015;26:281-90.
    PubMed     Text format     Abstract available


  478. ZHU TY, Griffith JF, Qin L, Hung VW, et al
    Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.
    Osteoporos Int. 2015;26:261-72.
    PubMed     Text format     Abstract available


    December 2014
  479. SHUAI B, Yang YP, Shen L, Zhu R, et al
    Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  480. HUANG ZB, Wan SL, Lu YJ, Ning L, et al
    Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  481. GIANGREGORIO LM, McGill S, Wark JD, Laprade J, et al
    Too Fit To Fracture: outcomes of a Delphi consensus process on physical activity and exercise recommendations for adults with osteoporosis with or without vertebral fractures.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  482. YAN Y, Xu R, Zou T
    Is thoracolumbar fascia injury the cause of residual back pain after percutaneous vertebroplasty? A prospective cohort study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  483. YU TM, Lin CL, Shu KH, Liu YL, et al
    Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  484. XIAO F, Qu X, Zhai Z, Jiang C, et al
    Association between loop diuretic use and fracture risk.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  485. KWON YM, Kim GW, Yim HW, Paek YJ, et al
    Association between dietary fat intake and bone mineral density in Korean adults: data from Korea National Health and Nutrition Examination Survey IV (2008 approximately 2009).
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  486. MARTINEZ-LAGUNA D, Tebe C, Javaid MK, Nogues X, et al
    Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  487. HUANG CY, Liao LC, Tong KM, Lai HL, et al
    Mediating effects on health-related quality of life in adults with osteoporosis: a structural equation modeling.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  488. BUCUR RC, Panjwani DD, Turner L, Rader T, et al
    Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  489. KRUSE C, Eiken P, Vestergaard P
    Hyponatremia and osteoporosis: insights from the Danish National Patient Registry.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  490. CHEN GD, Zhang ZG, Yang HL, Yang Y, et al
    Nonunion of osteoporotic vertebral compression fracture with a severe spinal stenosis treated in minimally invasive manner: a case report.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  491. OHTA H, Solanki J
    Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    November 2014
  492. BONE HG, Dempster DW, Eisman JA, Greenspan SL, et al
    Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  493. BERGLUNDH S, Malmgren L, Luthman H, McGuigan F, et al
    C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  494. SUGIMOTO T, Matsumoto T, Hosoi T, Miki T, et al
    Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  495. OLENGINSKI TP, Maloney-Saxon G, Matzko CK, Mackiewicz K, et al
    High-risk osteoporosis clinic (HiROC): improving osteoporosis and postfracture care with an organized, programmatic approach.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  496. COSTA TL, Paganotto M, Radominski RB, Kulak CM, et al
    Calcium metabolism, vitamin D and bone mineral density after bariatric surgery.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  497. KALDER M, Kyvernitakis I, Albert US, Baier-Ebert M, et al
    Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  498. LAURENT MR, Gielen E, Vanderschueren D
    Estrogens, the be-all and end-all of male hypogonadal bone loss?
    Osteoporos Int. 2014.
    PubMed     Text format    


  499. ROTHMANN MJ, Ammentorp J, Bech M, Gram J, et al
    Self-perceived facture risk: factors underlying women's perception of risk for osteoporotic fractures: the Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE).
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available



  500. IOF Regionals - 5 Asia-Pacific Osteoporosis Meeting : Poster Presentations.
    Osteoporos Int. 2014;25.
    PubMed     Text format    



  501. IOF Regionals - 5 Asia-Pacific Osteoporosis Meeting : Oral Communications.
    Osteoporos Int. 2014;25.
    PubMed     Text format    



  502. IOF Regionals - 5 Asia-Pacific Osteoporosis Meeting : Plenary Lectures.
    Osteoporos Int. 2014;25.
    PubMed     Text format    


    October 2014
  503. ROBINSON PJ, Bell RJ, Zecena Morales CS, Fradkin P, et al
    Minimal-trauma fracture in women with breast cancer surviving for at least 5 years from diagnosis.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  504. SHELTAWY AA, Criseno S, Gittoes NJ, Crowley RK, et al
    Fear of medication side effects is a barrier to optimal osteoporosis care.
    Osteoporos Int. 2014.
    PubMed     Text format    


    September 2014
  505. MOLFINO A, Aversa Z, Muscaritoli M
    Cortisol and the muscle-bone axis.
    Osteoporos Int. 2014;25:2331-2.
    PubMed     Text format    


    August 2014
  506. KAWALILAK CE, Johnston JD, Olszynski WP, Kontulainen SA, et al
    Characterizing microarchitectural changes at the distal radius and tibia in postmenopausal women using HR-pQCT.
    Osteoporos Int. 2014;25:2057-66.
    PubMed     Text format     Abstract available


  507. SALE JE, Bogoch E, Hawker G, Gignac M, et al
    Patient perceptions of provider barriers to post-fracture secondary prevention.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    July 2014
  508. NELSON SD, Nelson RE, Cannon GW, Lawrence P, et al
    Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  509. GIBSON-SMITH D, Klop C, Elders PJ, Welsing PM, et al
    The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  510. OMSLAND TK, Magnus JH
    Forecasting the burden of future postmenopausal hip fractures.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    June 2014
  511. DREW S, Sheard S, Chana J, Cooper C, et al
    Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available



  512. Eighth Bone Quality Seminar Proceedings 2013.
    Osteoporos Int. 2014;25 Suppl 3:S465-501.
    PubMed     Text format    


  513. YANG CY, Chen CH, Wang HY, Hsiao HL, et al
    Strontium ranelate related Stevens-Johnson syndrome: a case report.
    Osteoporos Int. 2014;25:1813-6.
    PubMed     Text format     Abstract available


  514. MACDONALD HM, Garland A, Burr J, Strachan A, et al
    Validation of a short questionnaire for estimating dietary calcium intakes.
    Osteoporos Int. 2014;25:1765-73.
    PubMed     Text format     Abstract available


  515. ROUX C, Briot K
    How long should we treat?
    Osteoporos Int. 2014;25:1659-66.
    PubMed     Text format     Abstract available


    May 2014
  516. HANSEN KE, Blank RD, Palermo L, Fink HA, et al
    What analytic method should clinicians use to derive spine T-scores and predict incident fractures in men? Results from the MrOS study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  517. DURAO SF, Gomes PS, Colaco BJ, Silva JC, et al
    The biomaterial-mediated healing of critical size bone defects in the ovariectomized rat.
    Osteoporos Int. 2014;25:1535-45.
    PubMed     Text format     Abstract available


  518. HERNANDEZ CJ, Lopez HK, Lane JM
    Theoretical consideration of the effect of drug holidays on BMD and tissue age.
    Osteoporos Int. 2014;25:1577-84.
    PubMed     Text format     Abstract available


  519. COSTA AG, Cremers S, Dworakowski E, Lazaretti-Castro M, et al
    Comparison of two commercially available ELISAs for circulating sclerostin.
    Osteoporos Int. 2014;25:1547-54.
    PubMed     Text format     Abstract available


    April 2014
  520. SIMON MJ, Beil FT, Ruther W, Busse B, et al
    High fluoride and low calcium levels in drinking water is associated with low bone mass, reduced bone quality and fragility fractures in sheep.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  521. TSAMPALIEROS A, Berkenstock MK, Zemel BS, Griffin L, et al
    Changes in trabecular bone density in incident pediatric Crohn's disease: a comparison of imaging methods.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  522. ZARCA K, Durand-Zaleski I, Roux C, Souberbielle JC, et al
    Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available



  523. Abstracts of the WCO-IOF-ESCEO, World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, 2-5 April 2014, Seville, Spain.
    Osteoporos Int. 2014;25 Suppl 2:73-445.
    PubMed     Text format    


  524. QIU C, Liu X, Wang J, Zhao Y, et al
    Estrogen increases the transcription of human alpha2-Heremans-Schmid-glycoprotein by an interplay of estrogen receptor alpha and activator protein-1.
    Osteoporos Int. 2014;25:1357-67.
    PubMed     Text format     Abstract available


  525. MILLER-MARTINEZ D, Seeman T, Karlamangla AS, Greendale GA, et al
    Marital histories, marital support, and bone density: findings from the Midlife in the United States Study.
    Osteoporos Int. 2014;25:1327-35.
    PubMed     Text format     Abstract available


    March 2014
  526. LEUNG KS, Li CY, Tse YK, Choy TK, et al
    Effects of 18-month low-magnitude high-frequency vibration on fall rate and fracture risks in 710 community elderly-a cluster-randomized controlled trial.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  527. CANO A, Mendoza N, Sanchez-Borrego R
    Sequential use of antiresorptives in younger women.
    Osteoporos Int. 2014;25:1191-2.
    PubMed     Text format    


    February 2014
  528. DONNEAU AF, Reginster JY
    Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice.
    Osteoporos Int. 2014;25:397-8.
    PubMed     Text format    


  529. ABRAHAMSEN B, Grove EL, Vestergaard P
    Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.
    Osteoporos Int. 2014;25:757-62.
    PubMed     Text format     Abstract available


  530. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
    Osteoporos Int. 2014;25:441-6.
    PubMed     Text format     Abstract available


  531. HAGE MP, El-Hajj Fuleihan G
    Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.
    Osteoporos Int. 2014;25:423-39.
    PubMed     Text format     Abstract available


  532. MATEOS F, Valero C, Olmos JM, Casanueva B, et al
    Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia.
    Osteoporos Int. 2014;25:525-33.
    PubMed     Text format     Abstract available


  533. MACINTYRE NJ, Lorbergs AL, Adachi JD
    Inclinometer-based measures of standing posture in older adults with low bone mass are reliable and associated with self-reported, but not performance-based, physical function.
    Osteoporos Int. 2014;25:721-8.
    PubMed     Text format     Abstract available


  534. PHAN V, Blydt-Hansen T, Feber J, Alos N, et al
    Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
    Osteoporos Int. 2014;25:627-37.
    PubMed     Text format     Abstract available


  535. BANG UC, Hyldstrup L, Jensen JE
    The impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registers.
    Osteoporos Int. 2014;25:639-44.
    PubMed     Text format     Abstract available


  536. LAZARUS S, Zankl A, Duncan EL
    Next-generation sequencing: a frameshift in skeletal dysplasia gene discovery.
    Osteoporos Int. 2014;25:407-22.
    PubMed     Text format     Abstract available


  537. SHIN D, Kim S, Kim KH, Park SM, et al
    Importance of fat mass and lean mass on bone health in men: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV).
    Osteoporos Int. 2014;25:467-74.
    PubMed     Text format     Abstract available


    December 2013
  538. ITO M, Oishi R, Fukunaga M, Sone T, et al
    The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    November 2013
  539. RAJAPAKSE CS , Phillips EA, Sun W, Wald MJ, et al
    Vertebral deformities and fractures are associated with MRI and pQCT measures obtained at the distal tibia and radius of postmenopausal women.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    October 2013
  540. BOTTAI V , Giannotti S, Dell'osso G, De Paola G, et al
    Atypical femoral fractures: retrospective radiological study of 319 femoral fractures and presentation of clinical cases.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    September 2013
  541. EEKMAN DA , van Helden SH, Huisman AM, Verhaar HJ, et al
    Optimizing fracture prevention: the fracture liaison service, an observational study.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    July 2013
  542. ACU K , Scheel M, Issever AS
    Time dependency of bone density estimation from computed tomography with intravenous contrast agent administration.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: